Adverum Biotechnologies (ADVM) P/E (2016 - 2026)
Adverum Biotechnologies (ADVM) P/E from Jan 4, 2016 to Jul 21, 2026. The TTM Adverum Biotechnologies (ADVM) P/E is -0.53. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Adverum Biotechnologies (ADVM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.53 | N/A |
| 2025 | -0.53 | -9.38% |
| 2024 | -0.59 | +4.35% |
| 2023 | -0.56 | +57.95% |
| 2022 | -0.36 | -70.61% |
| 2021 | -1.22 | -85.29% |
| 2020 | -8.27 | -12.96% |
| 2019 | -9.50 | +265.71% |
| 2018 | -2.60 | +10.96% |
| 2017 | -2.34 | +138.09% |
| 2016 | -0.98 | N/A |
Comparison Adverum Biotechnologies (ADVM) P/E with competitors
Adverum Biotechnologies (ADVM) P/E is -0.53.